Geha John A, Geha Joseph D, Goss Matthew, Kueht Michael L, Cotton Ronald T, Rana Abbas, Goss John A, Bhakta Kirti, Swartz Sarah J, O'Mahony Christine A, Brewer Eileen D, Galvan Nhu T N
Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Renal Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Pediatr Transplant. 2019 Sep;23(6):e13497. doi: 10.1111/petr.13497. Epub 2019 Jun 18.
Kidney transplantation is the treatment of choice in pediatric patients with end-stage renal disease. This population presents technical challenges particularly in those less than 20 kg due to anomalous anatomy, vascular access issues prior to transplantation, and a generally small size for age. Standard allograft outflow is usually achieved utilizing the iliac veins or IVC. When use of the iliocaval system is not feasible, alternative anastomosis must be considered. Herein, we report a case of a pediatric kidney transplantation where successful allograft outflow was achieved using the SMV when he was found to have an atretic IVC intraoperatively. In this setting, use of the portal system was required to achieve adequate allograft outflow. We created a donor iliac graft for added length to anastomose the renal vein with the SMV. In the setting of IVC occlusion with poor drainage, we utilized a patent vessel with larger caliber for outflow to reduce the risk of high venous pressures, allograft failure, venous rotation, and thrombosis. We conclude that the SMV may serve as an alternative outflow tract in the small pediatric patient and provides the vessel caliber needed to reduce the risks of complications.
肾移植是终末期肾病患儿的首选治疗方法。由于解剖结构异常、移植前血管通路问题以及总体上年龄对应的体型较小,这一群体尤其在体重不足20公斤的患儿中存在技术挑战。标准的同种异体移植物流出道通常利用髂静脉或下腔静脉来实现。当使用髂腔静脉系统不可行时,必须考虑替代吻合方式。在此,我们报告一例小儿肾移植病例,术中发现患儿下腔静脉闭锁,通过使用肠系膜上静脉成功实现了同种异体移植物流出。在这种情况下,需要使用门静脉系统来实现足够的同种异体移植物流出。我们制作了一段供体髂血管移植物以增加长度,用于将肾静脉与肠系膜上静脉吻合。在存在下腔静脉闭塞且引流不佳的情况下,我们利用口径较大的通畅血管进行流出,以降低高静脉压、同种异体移植物失败、静脉扭转和血栓形成的风险。我们得出结论,肠系膜上静脉可作为小儿患者的替代流出道,并提供降低并发症风险所需的血管口径。